Alternate-day, low-dose aspirin and cancer risk.

Alternate-day, low-dose aspirin and cancer risk.

Detalles Bibliográficos
Autor principal:	Rothwell, P
Formato:	Journal article
Lenguaje:	English
Publicado:	2013

Ejemplares similares

Effects on colon cancer risk in randomised trials of aspirin
por: Rothwell, P
Publicado: (2011)

Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
por: García Rodríguez, L, et al.
Publicado: (2016)

Aspirin in the prevention of cancer Reply
por: Rothwell, P
Publicado: (2011)

Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
por: Luis A García Rodríguez, et al.
Publicado: (2016-01-01)

Low-dose aspirin for migraine prophylaxis.
por: Buring, J, et al.
Publicado: (1990)

Low-dose aspirin for the prevention of atherothrombosis.
por: Patrono, C, et al.
Publicado: (2005)

LOW-DOSE ASPIRIN IN PREGNANCY AND EARLY-CHILDHOOD DEVELOPMENT - FOLLOW-UP OF THE COLLABORATIVE LOW-DOSE ASPIRIN STUDY IN PREGNANCY
por: Farrell, B, et al.
Publicado: (1995)

Thirty day low-dose versus regular-dose aspirin for venous thromboembolism prophylaxis in primary total joint arthroplasty
por: Alexander J. Duke, et al.
Publicado: (2023-05-01)

Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits.
por: Rothwell, P
Publicado: (2013)

Analysis of the Occurrence of Major Hemorrhagic Incidents in Patients with Low-Dose Aspirin Usage in Korean Populations – Does Low-Dose Aspirin Really Increase the Risk of Bleeding?
por: Tae Gon Kim, et al.
Publicado: (2020-03-01)

Individual-patient meta-analysis: Daily aspirin reduces risk for incident cancer with distant metastasis
por: Rothwell, P
Publicado: (2012)

Low-dose Btk inhibitors: an ‘aspirin’ of tomorrow?
por: Bernard Payrastre, et al.
Publicado: (2021-01-01)

Application of low dose aspirin in pre-eclampsia
por: Yu Ren, et al.
Publicado: (2023-03-01)

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
por: Harald Vonkeman, et al.
Publicado: (2010-10-01)

Aspirin, salicylates and cancer
por: Morgan, G, et al.
Publicado: (2011)

Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin Consumers
por: Anca Negovan, et al.
Publicado: (2016-01-01)

Potential biomarker for aspirin use in colorectal cancer therapy.
por: Langley, R, et al.
Publicado: (2013)

Commentary: aspirin and colorectal cancer an epidemiological success story.
por: Flossmann, E, et al.
Publicado: (2007)

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
por: Rothwell, P, et al.
Publicado: (2018)

Effects of Low-Dose Aspirin Therapy on Thermoregulation in Firefighters
por: Serina J. McEntire, et al.
Publicado: (2015-09-01)

Effects of low-dose aspirin on the osseointegration process in rats
por: Ana Carolina Lupepsa, et al.
Publicado: (2021-01-01)

Low-dose aspirin as treatment for central serous chorioretinopathy
por: Antonio Caccavale, et al.
Publicado: (2010-08-01)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
por: Patrono, C, et al.
Publicado: (2005)

Low dose aspirin blocks breast cancer-induced cognitive impairment in mice.
por: Adam K Walker, et al.
Publicado: (2018-01-01)

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
por: Flossmann, E, et al.
Publicado: (2007)

Venous Thromboembolism and Risk of Cancer in Users of Low-Dose Aspirin: A Danish Population-Based Cohort Study
por: Gencer Kurt, et al.
Publicado: (2022-07-01)

Needs-based considerations for the role of low-dose aspirin along the CV risk continuum
por: Francesca Santilli, et al.
Publicado: (2024-06-01)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Hamzah Khan, et al.
Publicado: (2022-08-01)

Risk threshold for starting low dose aspirin in pregnancy to prevent preeclampsia: an opportunity at a low cost.
por: Emily Bartsch, et al.
Publicado: (2015-01-01)

Letter to Editor regarding article, “Thirty day low-dose versus regular-dose aspirin for venous thromboembolism prophylaxis in primary total joint arthroplasty”
por: Sheng Zhao, et al.
Publicado: (2023-08-01)

Safety of Continuous Low-Dose Aspirin Therapy for Cervical Laminoplasty
por: Tetsuji Inoue, et al.
Publicado: (2022-05-01)

Low dose aspirin therapy and renal function in elderly patients
por: Akinwusi PO, et al.
Publicado: (2013-01-01)

Biological markers: Potential biomarker for aspirin use in colorectal cancer therapy
por: Langley, R, et al.
Publicado: (2013)

Platelet inhibition by low-dose aspirin is not influenced by body mass or weight
por: Sean P. Heffron, et al.
Publicado: (2022-11-01)

Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats
por: Rachel Shvartsur, et al.
Publicado: (2022-04-01)

Aspirin and endometrial cancer risk
por: Theodore M. Brasky, et al.
Publicado: (2016-08-01)

Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug
por: Annachiara Mitrugno, et al.
Publicado: (2018-11-01)

Evaluation of post-extraction bleeding in patients taking low dose aspirin
por: Sajid Hasan, et al.
Publicado: (2019-04-01)

Safety and Clinical Results of Continuous Low-Dose Aspirin in Microendoscopic Laminectomy
por: Kiyoshi Tarukado, et al.
Publicado: (2023-07-01)

Evaluation the effect of low-dose aspirin on endothelial dysfunction in preeclamptic patients
por: Mohammad Hashemi, et al.
Publicado: (2016-01-01)